Pfizer Positions For First-In-Class Nasal Corticosteroid Switch
This article was originally published in The Tan Sheet
Executive Summary
Rhinocort Aqua could be a first-in-class U.S. switch for the nasal corticosteroids, often cited as a potential class for switches. Pfizer gains right of first refusal for the product’s OTC rights from AstraZeneca.